Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant SBRT and Chemotherapy in Resected Pancreatic Cancer
NCT02461836Phase 2Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Aug 2015
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Disease-Free Survival at 36 months. Status: unknown.
Beyond the preview
Go deeper on NCT02461836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02461836.